APIs

Cinacalcet Hydrochloride

Cinacalcet (INN) is a drug that acts as a calcimimetic (i.e. it mimics the action of calcium on tissues) by allosteric activation of the calcium-sensing receptor that is expressed in various human organ tissues. It is sold by Amgen under the trade name Sensipar® in North America and Australia and as Mimpara® in Europe. Cinacalcet is used to treat hyperparathyroidism (elevated parathyroid hormone levels), a consequence of parathyroid tumors and chronic renal failure....
Products Inquiry

Description

Product Name:   Cinacalcet Hydrochloride
Synonyms:   (aR)-a-Methyl-N-[3-[3-(trifluoromethyl)phenyl)propyl]-1-napthalenemethanamine Hydrochloride; Cinacalcet HCL
Description:   White to off-white solid
Cas No.:   364782-34-3
Molecular Formula:   C22H23ClF3N
Molecular Weight:   393.88
Purity:   99%HPLC
Quality Standard:   BP/EP/USP
Usage:   Treatment of hyperthyroidism and hypercalcemia